These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21895535)

  • 1. Human involucrin promoter mediates repression-resistant and compartment-specific LEKTI expression.
    Di WL; Semenova E; Larcher F; Del Rio M; Harper JI; Thrasher AJ; Qasim W
    Hum Gene Ther; 2012 Jan; 23(1):83-90. PubMed ID: 21895535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome-derived skin grafts.
    Di WL; Larcher F; Semenova E; Talbot GE; Harper JI; Del Rio M; Thrasher AJ; Qasim W
    Mol Ther; 2011 Feb; 19(2):408-16. PubMed ID: 20877344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome.
    Di WL; Mellerio JE; Bernadis C; Harper J; Abdul-Wahab A; Ghani S; Chan L; Martinez-Queipo M; Hara H; McNicol AM; Farzaneh F; McGrath J; Thrasher A; Qasim W
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):182-90. PubMed ID: 24329107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial.
    Di WL; Lwin SM; Petrova A; Bernadis C; Syed F; Farzaneh F; Moulding D; Martinez AE; Sebire NJ; Rampling D; Virasami A; Zamiri M; Wang W; Hara H; Kadiyirire T; Abdul-Wahab A; Martinez-Queipo M; Harper JI; McGrath JA; Thrasher AJ; Mellerio JE; Qasim W
    Hum Gene Ther; 2019 Sep; 30(9):1067-1078. PubMed ID: 31288584
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Park NJ; Jo BG; Bong SK; Park SA; Lee S; Kim YK; Yang MH; Kim SN
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
    Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
    Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study protocol for ex-vivo lentiviral gene therapy for the inherited skin disease, Netherton Syndrome.
    Di WL; Mellerio JE; Bernadis C; Harper J; Abdul-Wahab A; Ghani S; Martinez-Queipo M; Hara H; McNicol AM; McGrath J; Thrasher AJ; Qasim W
    Hum Gene Ther Clin Dev; 2013 Oct; ():. PubMed ID: 24138501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
    Meyer-Hoffert U; Wu Z; Schröder JM
    PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes.
    Le NA; Katsuyama M; Demura M; Tanii H; Katsuyama H; Saijoh K
    Environ Health Prev Med; 2014 Jul; 19(4):307-13. PubMed ID: 24894987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene.
    van Til NP; de Boer H; Mashamba N; Wabik A; Huston M; Visser TP; Fontana E; Poliani PL; Cassani B; Zhang F; Thrasher AJ; Villa A; Wagemaker G
    Mol Ther; 2012 Oct; 20(10):1968-80. PubMed ID: 22692499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing.
    Tartaglia-Polcini A; Bonnart C; Micheloni A; Cianfarani F; Andrè A; Zambruno G; Hovnanian A; D'Alessio M
    J Invest Dermatol; 2006 Feb; 126(2):315-24. PubMed ID: 16374478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
    Roedl D; Oji V; Buters JT; Behrendt H; Braun-Falco M
    J Dermatol Sci; 2011 Mar; 61(3):194-8. PubMed ID: 21251800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a mouse model of Netherton syndrome based on CRISPR/Cas9 technology.
    Guo JZ; Su J; Dai H; Wang XY; Wu WB; Chen T; Zhang J; Wang WH
    Eur J Dermatol; 2022 Jul; 32(4):459-463. PubMed ID: 36301754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon-Specific U1s Correct SPINK5 Exon 11 Skipping Caused by a Synonymous Substitution that Affects a Bifunctional Splicing Regulatory Element.
    Dal Mas A; Fortugno P; Donadon I; Levati L; Castiglia D; Pagani F
    Hum Mutat; 2015 May; 36(5):504-12. PubMed ID: 25665175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo.
    Herbst F; Ball CR; Tuorto F; Nowrouzi A; Wang W; Zavidij O; Dieter SM; Fessler S; van der Hoeven F; Kloz U; Lyko F; Schmidt M; von Kalle C; Glimm H
    Mol Ther; 2012 May; 20(5):1014-21. PubMed ID: 22434137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comèl-Netherton syndrome defined as primary immunodeficiency.
    Renner ED; Hartl D; Rylaarsdam S; Young ML; Monaco-Shawver L; Kleiner G; Markert ML; Stiehm ER; Belohradsky BH; Upton MP; Torgerson TR; Orange JS; Ochs HD
    J Allergy Clin Immunol; 2009 Sep; 124(3):536-43. PubMed ID: 19683336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugimoto S; Morizane S; Nomura H; Kobashi M; Sugihara S; Iwatsuki K
    J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression.
    Krinner S; Heitzer A; Asbach B; Wagner R
    Hum Gene Ther; 2015 Dec; 26(12):826-40. PubMed ID: 26414116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins.
    Di WL; Hennekam RC; Callard RE; Harper JI
    Br J Dermatol; 2009 Aug; 161(2):404-12. PubMed ID: 19438860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
    Komatsu N; Saijoh K; Jayakumar A; Clayman GL; Tohyama M; Suga Y; Mizuno Y; Tsukamoto K; Taniuchi K; Takehara K; Diamandis EP
    J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.